Investegate |Active Biotech Announcements | Active Biotech: Active Biotech's nomination committee appointed
Investegate announcements from Active Biotech, Active Biotech's nomination committee appointed
Stay updated with breaking news from Active Biotech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investegate announcements from Active Biotech, Active Biotech's nomination committee appointed
In accordance with a decision made by the Annual General Meeting held on May 19, 2021, the Nomination Committee shall comprise the representatives for the three largest shareholders by votes, as per end
Lund, Sweden - November 30, 2021 - Active Biotech and its partner NeoTX announced that the preclinical data on naptumomab enhancing the potency of CAR-T cells was presented on Nov 12th at the Society for
"We have seen the first encouraging results from the ongoing tasquinimod trial in multiple myeloma and started a new combination study with naptumomab and docetaxel in lung cancer" THIRD QUARTER
Lund, November 4, 2021 - Active Biotech (NASDAQ STOCKHOLM: ACTI) today announced that two abstracts with new preclinical data on tasquinimod, a small molecule immunomodulator, have been accepted for presentation